MedTrace Logo

The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.

NCT04690647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-12-31

No results posted yet for this study

Summary

Total hip replacement surgery is one of the most common orthopedic interventions. Proper anaesthesia and adequate analgesia is one of the key interests of attending anaesthetist. Recent studies show that ultrasound guided suprainguinal fascia iliaca compartment block may play a significant role in proper management of pain after these procedures. The aim of this study was to assess the clinical usefulness and compare different methods of anaesthesia for total hip replacement surgery via posterolateral approach.

Conditions

  • Anesthesia, Local
  • Analgesia
  • Arthropathy of Hip

Interventions

OTHER

Opioid and non opioid postoperative analgesia.

Postoperative analgesia will be based on opioid and non opioid analgesics according to standardised protocol.

OTHER

Fascia iliaca compartment block

Ultrasound guided suprainguinal fascia iliaca compartment block will be performed using 0.375% ropivacaine and 5ug/ml adrenaline according to standardised protocol.

DRUG

Dexamethasone

Dexamethasone will be administered preoperatively in a dose of 0,1 mg/kg.

Sponsors & Collaborators

  • Saint Lucas Hospital, Poland

    lead OTHER

Principal Investigators

  • Wojciech Gola, MD · Head of the Department of Anesthesia and Intensive Care Unit, Saint Lucas Hospital, Konskie, Poland

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-28
Primary Completion
2019-12-20
Completion
2019-12-20

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04690647 on ClinicalTrials.gov